Codex @codex  0

Autophosphorylation is phosphorylation of a protein kinase by its own catalytic activity or that of another member of the same protein kinase assembly. Distinguish modification within one chain from trans-autophosphorylation between partners.

Energy coupling links an endergonic reaction to an exergonic reaction through a reaction mechanism, so that the combined transformation has a favourable change in Gibbs free energy. ATP hydrolysis is a common driving chemical reaction. A shared reaction intermediate, produced in one step and consumed in another, can physically connect the transformations; merely placing two independent chemical reactions in the same chemical solution does not establish energy coupling. See Alberts et al., Molecular Biology of the Cell: coupled reactions and activated intermediates.

For a computed example, stipulate an endergonic reaction $\mathrm{A}⟶\mathrm{B}$ with $\Delta G_1^{\circ \prime }=+20\mathrm{kJ}\mathrm{mo}{\mathrm{l}}^{-1}$ under precisely the same biochemical standard state conditions as the quoted ATP hydrolysis value. Assume a reaction mechanism couples one ATP hydrolysis to each A-to-B conversion. The formal sum isThe sum $+20+(-30.5)=-10.5$ gives an exergonic reaction. The $+20$ is a chosen teaching value, not a measured property of an identified substance. Outside these reference conditions, add the actual $\Delta G_1$ and $\Delta G_2$, each evaluated using consistent thermodynamic activities; mixing a standard value for one chemical reaction with an unrelated cellular value for the other gives no justified prediction.

Why do the changes in Gibbs free energy add? Gibbs free energy is a state function. Adding consistent reaction changes cancels any shared reaction intermediate and leaves the difference between the combined reactants and combined reaction products. This explains the thermodynamic accounting; it does not construct the reaction mechanism. In many ATP-dependent routes, phosphorylation transfers a phosphate group to a substrate or an enzyme, and subsequent transformation consumes that modified material. The shared material is what connects the steps. Other reaction mechanisms use ATP differently. See Alberts et al., Molecular Biology of the Cell: ATP-driven biosynthesis.

The useful achievement is that a common regenerated nucleotide can connect many different processes in metabolism. The net negative change in Gibbs free energy permits the coupled conversion, but supplies no reaction rate: enzymes can lower activation energy barriers without changing the endpoint difference. Energy coupling changes which overall chemical reaction is being considered; catalysis accelerates an available route. See OpenStax Biology 2e, 6.2: free-energy changes and reaction barriers.

A historical landmark is Fritz Lipmann's ^[ref]. Its sections on the phosphate cycle, generation and utilization of phosphate-bond energy, and group transfer organized these processes around a reusable chemical carrier. The historical terminology should be read with the modern distinction between net hydrolysis and the cost of breaking a chemical bond.

In Receptor sensitivity in bacterial chemotaxis by Victor Sourjik and others, Victor Sourjik and Howard C. Berg used a cyan fluorescent tag on CheZ as FRET donor and a yellow tag on CheY as FRET acceptor. Escherichia coli biological cells adhered to a polylysine-coated coverslip in a continuously perfused chamber. A fluorescence microscope excited them with a $442$-nanometre laser; split emission bands fed two photon-counting detectors. The yellow/cyan emission ratio fell when attractant was added and rose when it was removed.^[ref]

Saturating attractant increased cyan emission by an amount matching selective bleaching of the yellow tag: removing the FRET acceptor supported relief of FRET donor transfer. Strains carrying the tagged pair but lacking other chemotaxis machinery showed no stimulus-dependent emission ratio change. Weak illumination reduced bleaching drift.^[ref]

The inference is a change in the population of nearby tagged CheY/CheZ pairs associated with CheY phosphorylation. It neither measures each pair's separation nor directly observes motor motion. The readout also averages many biological cells, and perfusion takes finite time. The pathway interpretation belongs to the chemotaxis FRET assay; the general measurement lesson is that molecular association can alter FRET while the geometry of an individual associated pair stays the same.

Glucagon is a peptide hormone made by alpha cells in the pancreatic islets. Its mature polypeptide has 29 amino acid residues. Alpha cells store glucagon in secretory granules and release it by exocytosis. Glucagon is a message about fuel availability; glucose is the sugar whose supply it helps regulate. A falling blood glucose concentration favors glucagon release, whereas a rise usually suppresses it. Amino acids can also stimulate release, so a meal containing protein need not produce the same hormone pattern as a meal dominated by carbohydrates. ^[ref]

The principal blood glucose-raising target is the liver. In a hepatocyte, the glucagon receptor is a G protein-coupled receptor: activation of a stimulatory G protein drives adenylyl cyclase, increasing the second messenger cAMP and activating protein kinase A. Downstream phosphorylation, including the phosphorylase kinase relay to glycogen phosphorylase, favors glycogenolysis. Glucagon also supports gluconeogenesis. These are different supplies: glycogenolysis draws on a finite glycogen reserve, whereas gluconeogenesis makes glucose from other substrates and depends on their availability. Longer fasting depletes the glycogen reserve; a stronger hormone signal cannot release material that is no longer there. ^{[ref] [ref]}

Do not copy the liver pathway into every target of insulin. Skeletal muscle uses its own glycogen reserve locally; its glucose uptake and the liver's glucose output are different flows. Nor is direct glucagon-stimulated lipolysis in human adipose tissue as firmly established as its action in the liver. Glucagon action depends on the tissue, other hormones, and available substrates. ^[ref]

There is a useful surprise inside the pancreatic islets: local glucagon can support insulin release from neighboring beta cells. The islet perifusion experiment distinguishes that interaction from glucagon's action on the liver. Thus the two hormones can oppose each other's effects on blood glucose while cooperating locally. Delta cells supply another local brake through somatostatin. ^{[ref] [ref]}

A metabotropic receptor couples ligand recognition to intracellular signal transduction, which can regulate a separate ion channel, alter enzyme activity or change gene expression. In the usual neurotransmitter context, metabotropic receptors are G protein-coupled receptors: receptor activation is relayed by a G protein. There need not be a change in membrane potential at all. ^[ref]

Two routes should be distinguished. An activated G protein can regulate an ion channel locally at the cell membrane, without an obligatory diffusible second messenger. Alternatively, it can regulate an enzyme that changes the availability of a second messenger, such as cAMP or inositol trisphosphate. Downstream proteins then change channel opening, phosphorylation or other cellular activities. The receptor, G protein, second messenger and final target are distinct components; an activated G protein is a relay protein, rather than itself a small-molecule second messenger.^[ref]

Do not turn this useful chemical synapse classification into the claim that every receptor is a GPCR, or that every indirect response must pass through a G protein. For example, the insulin receptor is an enzyme-linked cell-surface receptor whose intracellular catalytic activity initiates protein phosphorylation. Intracellular receptors supply another category. “Metabotropic” commonly names the GPCR branch in neuroscience; the broader idea of biochemical coupling does not make all non-channel receptors structurally identical. ^[ref]

Separating recognition from execution allows signal amplification and branching. A persistently activated receptor can activate several relay proteins; a regulated enzyme can produce many second messenger molecules. As an explicitly invented count example, suppose one activated receptor activates four relay proteins during one interval, and each relay activates a distinct enzyme that produces fifteen second messenger molecules during the next interval. With sufficient substrates and no loss, this gives $4\times 15=60$ molecules. Those counts do not specify a physiological gain or response duration. A directly gated ion channel also passes many ions while open, so amplification is not an exclusive property of metabotropic receptors: always name the input and output being compared. ^[ref]

A particularly instructive electrophysiology experiment separated a chemical trigger from the ion channel carrying its eventual electric current. In 1987, Hirono, Ito and Sugiyama injected messenger RNA from rat brain into frog egg cells, then tested acquired responses to neurotensin and muscarinic acetylcholine stimulation. Under voltage clamp at $-60\mathrm{mV}$, neurotensin elicited transient, oscillatory inward electric currents after a delay of several tens of seconds. This delay refers to that response and preparation. Reversal potential measurements implicated increased permeability to chloride anions, rather than a pore specific to the applied ligand. Both neurotensin and acetylcholine responses were inhibited by pertussis toxin, which interferes with susceptible G proteins, and by intracellular EGTA, which binds free calcium. Injecting inositol trisphosphate mimicked the responses; a large prior dose of inositol trisphosphate reduced subsequent responses to either extracellular signal. These interventions implicate a shared intracellular relay and calcium-dependent channel opening.^[ref]

The informative comparison with the nicotinic acetylcholine receptor experiment is mechanistic: an extracellular ligand can produce an inward electric current either by directly gating the pore or by mobilizing an intracellular second messenger and stored calcium that activate another pore. Intracellular inositol trisphosphate bypasses reception, whereas EGTA tests the need for free calcium. However, neither inhibition nor mimicry alone identifies every molecular connection: a perturbation can affect several targets, and an injected mediator can activate a pathway without proving that it is the only natural route. The egg cell's endogenous machinery and the mixed messenger RNA preparation also limit extrapolation to an intact neuron. The experiment establishes functional coupling in its preparation, rather than the exact molecular composition or timing of every metabotropic receptor.

Even G protein-dependent channel regulation need not involve a lengthy second messenger cascade. Pfaffinger and colleagues reported in 1985 that acetylcholine-evoked potassium channel activation in embryonic chick atrial cells required intracellular GTP, a guanine-containing nucleotide, and was abolished by pertussis-toxin pretreatment. Changes in cyclic nucleotides, including cAMP, did not account for the channel response. The report discusses intrinsic activation delays of roughly $30$–$100\mathrm{ms}$, illustrating relatively rapid metabotropic receptor action. These observations support a G protein coupling step without cyclic-nucleotide second messengers; they do not by themselves exclude every possible intermediary or prove the specific subunit-channel interaction.^[ref]

A small timing model makes the extra steps visible without inventing an experimental trace. Let $u(t)$ jump from zero to one at $t=0$ and remain on. For a direct-gating model output $d$, one relay variable $x$, and its downstream output $y$, take zero initial conditions andAll outputs are normalized dimensionless variables; they are neither recorded electric currents nor fitted concentrations. With illustrative time constants ${\tau }_d=2\mathrm{ms}$, ${\tau }_x=20\mathrm{ms}$ and ${\tau }_y=100\mathrm{ms}$, their exponential function solutions for $t\ge 0$ areInitially $d^{\prime }(0)=1/{\tau }_d$, while $y^{\prime }(0)=0$ because its relay must first build up. Both outputs eventually approach one. Equal normalized final values do not imply equal biological amplitudes or absence of signal amplification; normalization deliberately removes that question.

The model's useful feature is the delayed buildup created by sequential relaxation, not its arbitrary numbers. Actual kinetics also depend on ligand delivery, relay deactivation, neurotransmitter clearance and the final target. A local G protein route can act promptly, while an ionotropic receptor can remain active during continued exposure or feed a longer-lasting intracellular response. The beauty of metabotropic receptor coupling is its flexibility: the same recognition event can adjust electrical responsiveness and other cellular tasks through different targets. To classify an observed response, combine timing with molecular identity and controlled perturbations.

Negative feedback closes a causal loop whose net effect opposes an initiating change. In signal transduction, activation followed by a downstream inhibition of the earlier activating stage is one example of negative feedback. Loop sign alone does not establish asymptotic stability or complete signaling adaptation; see the worked signaling feedback example.

A useful biological example is chemotaxis feedback regulation: an Escherichia coli biological cell adjusts its response to a sustained attractant instead of remaining at its immediate response. Increased CheA activity promotes CheB phosphorylation; CheB reverses receptor methylation, opposing their activation. After attractant addition, reduced activity instead favors receptor methylation by CheR, restoring activity. This is a return from receptor activity to the machinery regulating that activity. The response need not return exactly at every dose. ^[ref]

A motivating measurement is the chemotaxis FRET assay. CheY and CheZ carrying yellow and cyan fluorescent tags were observed in immobilized Escherichia coli biological cells on a coverslip in a flow chamber. Adding and removing attractant changed the yellow-to-cyan emission ratio, reporting the association of phosphorylated CheY with CheZ. This measures a molecular readout upstream of motor behavior. Comparisons with biological cells lacking CheR, CheB, or both tested the dependence on receptor modification; these perturbations also change starting activity and sensitivity, so they are not pure changes of one feedback gain. ^[ref]

The later chemotaxis feedback regulation experiment used only the Tar receptor and nonmetabolizable methylaspartate, supplied and removed by flow. Long recordings separated slow recovery from incomplete signaling adaptation; correction for bleaching addressed drift in the optical readout. Activity recovered incompletely after sufficiently large additions, with detectable imprecision already at $10\mu \mathrm{M}$ in that preparation. Restricting the receptor type and preventing consumption of the stimulus help interpret the perturbation, but limit transfer to other receptors and conditions. The readout infers CheA activity through CheY-CheZ association, rather than directly measuring every molecular step. ^[ref]

Negative feedback can also overshoot or sustain oscillations if its return arrives too late. The worked signaling feedback example gives the contrasting instantaneous case; the delayed negative feedback model below isolates the effect of timing. Loop sign describes causation, while asymptotic stability describes what happens to displacements over time.

Phosphorylation attaches a phosphate group to a molecule. Transfer from ATP to a substrate or enzyme can participate in energy coupling; the name alone does not specify the complete reaction mechanism. See OpenStax Biology 2e, 6.4: phosphorylation.

Positive feedback closes a causal loop whose net effect reinforces an initiating change. A loop with two inhibitory links can therefore have positive feedback. In signal transduction, a product that increases the activity of the enzyme making it illustrates reinforcement; the consequences depend on the full mathematical model, not just the loop sign. See signaling feedback.

A biological example is cell-cycle activation feedback. Cyclin B binds Cdc2, whose activity promotes activation of Cdc25; Cdc25 removes inhibitory phosphorylation from Cdc2, permitting further activation. Cdc2 also inhibits Wee1, an enzyme that inhibits Cdc2 through phosphorylation. That second return contains two inhibitions and therefore also has positive feedback. These are regulatory paths, not a claim that every connection is a single direct molecular encounter. ^[ref]

Reinforcement can preserve a decision after its initiating stimulus weakens: returning from the high state may require a lower input than entering it. The cell-cycle hysteresis experiment below tests this history dependence at matched cyclin B concentrations. A steep response alone is insufficient evidence of bistability, and finite observation times can make slow relaxation look like memory. A proposed switch must specify its input, readout and observation interval.

A protein kinase is an enzyme that catalyzes phosphorylation of a protein. In receptor tyrosine kinase signaling, ATP supplies the transferred phosphate group.

A receptor tyrosine kinase combines extracellular ligand recognition with an intracellular protein kinase protein domain. A membrane-spanning segment connects these parts across the cell membrane: the signal changes the intracellular machinery without requiring the ligand to enter the cytosol. The protein kinase transfers a phosphate group from ATP to selected tyrosine residues on proteins, including the receptor itself.^[ref]

This architecture makes a reception event useful in two ways: it can change catalytic activity and assemble a local group of signaling proteins. Trans-autophosphorylation can create phosphotyrosine residues recognized by SH2 domains. Recruitment positions a downstream enzyme or relay protein near its partners. Neither every modified site nor every recruited protein has the same effect; association is a specific molecular connection, rather than a universal command to activate everything nearby.^[ref]

Compare the epidermal growth factor receptor with the insulin receptor. Their common topology does not impose one activation geometry or make assembly equivalent to activity. The receptor phosphorylation assay consequently needs more than evidence that two protein chains associate.

Signal amplification is an increase in a specified downstream response relative to an initiating signal. In a molecular-count description, one activated component can generate or activate many downstream molecules. Repeated catalysis by an enzyme supplies a mechanism: the enzyme remains available for another chemical reaction. Successive stages can multiply the response. For a biological example, Cooper describes the epinephrine-to-glycogen phosphorylase pathway, where production of many cAMP molecules and repeated downstream protein phosphorylation provide opportunities for signal amplification. This is an example, not a claim that every signal transduction pathway has the same stages or gain. ^[ref]

Here is a counting toy extending the example under signal transduction. Suppose $N_0$ activated receptors each activate $a=5$ distinct relay proteins during a first interval. During a subsequent interval, each relay activates $b=20$ distinct target proteins. Assume enough inactive relays and targets, no shared targets, and no loss of activity during the count. ThenFor $N_0=1$, this gives $N_1=5$ and $N_2=100$: the target-to-receptor count ratio is $100$. These are assumed integer counts, not measured rates or a universal physiological amplification factor. The intervals are sequential; the equations do not specify a time course.

Availability limits the multiplication. As a second toy assumption, let there be only $T=250$ initially inactive target proteins shared by all branches, and suppose the branches can activate distinct targets until this pool is exhausted. ThenTwo activated receptors give $200$ active targets, whereas three give $250$, not $300$. At three activated receptors, the total count ratio is $250/3\simeq 83.3$; adding a fourth activates no additional targets. Thus total output per input and the increment caused by an extra input are different notions of gain. This finite-pool rule is an illustrative bound, not an enzyme kinetics law.

Signal amplification makes a small initiating signal capable of a larger response, but it does not supply the material or energy for downstream chemical reactions. In the second messenger transfer experiment, both stages still required added ATP and magnesium ions. Counts, changes in concentration, and changes in enzyme activity are different readouts; an amplification claim should name its input, output and observation interval. ^[ref]